
Work Here?
Summary of QuantHealth: 1) What it does: QuantHealth uses an AI-powered platform to simulate clinical trials at scale, helping pharmaceutical companies and CROs de-risk and accelerate drug development. 2) How it works: It builds digital twins of patients from large datasets (over 350 million electronic health records, genomic data, and trial data) and runs virtual trials to predict how a real drug would perform, enabling evaluation of efficacy across many trial variations before real-world testing. 3) How it differs from competitors: It combines extensive real-world and genomic data to create detailed patient models (digital twins) and focuses on trial design optimization, patient subgroup identification, and rescuing underperforming trials, offering more data-driven insights than traditional methods. 4) Goal: To cut both the time and cost of bringing new drugs to market while increasing the chances of trial success for pharma companies and CROs.
Industries
Data & Analytics
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$22M
Headquarters
Tel Aviv-Yafo, Israel
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$22M
Below
Industry Average
Funded Over
4 Rounds
Industry standards
Health Insurance
401(k) Retirement Plan
Remote Work Options
QuantHealth, an AI-driven clinical trial simulation company, has reported 8x sales growth through new and expanding engagements with life sciences organisations, representing $5 billion in active R&D investments. The Tel Aviv-based company nearly doubled its clinical trial simulations to over 600 trials in 2025, achieving up to 90% accuracy across nearly 50 therapeutic areas, including oncology, respiratory, immunology and cardiometabolic diseases. QuantHealth's AI-powered platform uses biological and clinical data to help pharmaceutical and biotechnology companies improve clinical trial success rates. The technology addresses a significant industry challenge, as an estimated 90% of drugs fail in clinical trials, costing the pharmaceutical industry more than $50 billion annually. The company's simulations help identify promising drug candidates and predict patient responses to treatment.
Sanofi and QuantHealth have partnered to enhance AI-powered digital twins and clinical trial simulations, aiming to speed up drug development. Sanofi Ventures has made a strategic investment in QuantHealth, raising its total funding to $30 million. QuantHealth's platform uses real-world data and AI to simulate clinical trials, generating millions of digital twins to predict outcomes and optimize trial design, improving success rates, timelines, and cost efficiency.
QuantHealth, a pioneer in AI-driven clinical trial simulation, announced a strategic investment from Sanofi Ventures, the venture capital arm of global healt...
QuantHealth, an AI-driven clinical trial simulation company, has secured a strategic investment from Sanofi Ventures, the venture capital arm of Sanofi. This investment will help accelerate QuantHealth's efforts in using digital twin technologies for drug development, bringing its total funds raised to $30 million. The partnership aims to enhance clinical trial design and success rates through AI and real-world data.
QuantHealth, an AI-powered clinical trial simulation company, unveiled its Large Real-World Drug Model, a first-of-its-kind clinical trial foundation model that can process and utilize data from more than 100 million patients and billions of therapeutic datapoints in a single simulation.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$22M
Headquarters
Tel Aviv-Yafo, Israel
Founded
2020
Find jobs on Simplify and start your career today